亚洲成A人片在线观看无码3D_在线国产不卡_婷婷sese_色谷av性色av性色av_久久99久久久久_亚洲成人网av

Zhejiang Supor Pharmaceuticals Co., Ltd. is a APIs manufacturer that is strictly complies with the high standards of GMP. The company was founded in 2002, in Shaoxing City, which is the core city built in Dawan District of Zhejiang Province. It is close to Shanghai-Hangzhou-Ningbo Expressway and Hangzhou Bay, thus it is easy of access. The first phase was completed in 2008, covering an area of 60 mu. The second phase was started in 2017, covering an area of 100 mu. It is expected to be completed in 2020.

The company is committed to the research and development of new drug technologies, and it has high predominance in the development and production of anti-anaerobic drugs, anti-hypertensive drugs, anti-depressants and peptide drugs. At present, it has formed a unique product chain from research, production to sales. The company has professional workshops, strict quality management and testing systems, and a complete EHS management system.

The company's quality system has passed national GMP certification, Australian TGA certification, US FDA certification, and EU EDQM certification. Some products are sold in the domestic market, and the rest are mainly sold to the international market. The company has established a complete EHS system and passed the ISO14000 and 18000 system certification. The company attaches great importance to technology research and development, and is a national "high-tech enterprise". In addition, the company's R&D center has been identified as "Zhejiang High-tech Drug Research and Development Center".

Supor Pharmaceuticals is committed to improving the quality management system, continuously enhanching the professional quality of management team on drug production and management, and gradually stepping into the ranks of high-level API manufacturers. In future, the company will focus on the production of peptide drugs, and further transform into an high-end APIs and preparation enterprise, and strive to be the world's leading supplier of peptide drugs; furthermore, the company will actively promote green pharmaceuticals technology and become the leading modern pharmaceuticals company based on green chemical technology.